We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Targeting senescent cells with NKG2D-CAR T cells.
- Authors
Deng, Yushuang; Kumar, Avadh; Xie, Kan; Schaaf, Kristina; Scifo, Enzo; Morsy, Sarah; Li, Tao; Ehninger, Armin; Bano, Daniele; Ehninger, Dan
- Abstract
This study investigates the efficacy of NKG2D chimeric antigen receptor (CAR) engineered T cells in targeting and eliminating stress-induced senescent cells in vitro. Cellular senescence contributes to age-related tissue decline and is characterized by permanent cell cycle arrest and the senescence-associated secretory phenotype (SASP). Immunotherapy, particularly CAR-T cell therapy, emerges as a promising approach to selectively eliminate senescent cells. Our focus is on the NKG2D receptor, which binds to ligands (NKG2DLs) upregulated in senescent cells, offering a target for CAR-T cells. Using mouse embryonic fibroblasts (MEFs) and astrocytes (AST) as senescence models, we demonstrate the elevated expression of NKG2DLs in response to genotoxic and oxidative stress. NKG2D-CAR T cells displayed potent cytotoxicity against these senescent cells, with minimal effects on non-senescent cells, suggesting their potential as targeted senolytics. In conclusion, our research presents the first evidence of NKG2D-CAR T cells' ability to target senescent brain cells, offering a novel approach to manage senescence-associated diseases. The findings pave the way for future investigations into the therapeutic applicability of NKG2D-targeting CAR-T cells in naturally aged organisms and models of aging-associated brain diseases in vivo.
- Subjects
T cells; IMMUNOSENESCENCE; CELLULAR aging; CHIMERIC antigen receptors; CELL cycle; CYTOTOXINS; BRAIN diseases; FIBROBLASTS
- Publication
Cell Death Discovery, 2024, Vol 10, Issue 1, p1
- ISSN
2058-7716
- Publication type
Article
- DOI
10.1038/s41420-024-01976-7